Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-06-12

Alphatec Holdings (ATEC)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$10,260,507
Patrick Miles total, FY2025
89th
CEO pay percentile vs peers
77.8:1
CEO-to-median pay ratio
86.84%
Say-on-pay support, latest vote
Companies that benchmark against ATEC
17 companies name ATEC as a compensation peer

Each company listed discloses ATEC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ATEC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Patrick Miles$762,000$0$8,859,650$0$600,000$0$38,857$10,260,507
President, Chairman and Chief Executive Officer
Craig Hunsaker498,62504,515,9700257,50001,047,7776,319,872
Executive Vice President, People & Culture
Scott Lish485,00904,494,1540257,500034,5825,271,245
Chief Operating Officer
David Sponsel445,39003,024,6620450,000034,3553,954,407
Executive Vice President, Sales
J. Todd Koning480,77503,062,4440250,000036,6563,829,875
Executive Vice President and Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Patrick Miles$10,260,507
Craig Hunsaker6,319,872
Scott Lish5,271,245
David Sponsel3,954,407
J. Todd Koning3,829,875

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Keith ValentineDirector2026-05-07A43,847$8$330,606CommonForm 4 ↗
Keith ValentineDirector2026-05-07A56,1537420,586CommonForm 4 ↗
Keith ValentineDirector2026-05-07A35,0007245,000CommonForm 4 ↗
Keith ValentineDirector2026-06-10A32,01200CommonForm 4 ↗
David PelizzonDirector2026-06-10A32,01200CommonForm 4 ↗
David DemskiDirector2026-06-10A32,01200CommonForm 4 ↗
Quentin BlackfordDirector2026-06-10A32,01200CommonForm 4 ↗
Karen McGinnisDirector2026-06-10A32,01200CommonForm 4 ↗
Karen McGinnisDirector2026-06-10D6,050848,461CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
J. Todd KoningRSU2025-01-29133,920$1,615,075
J. Todd KoningRSU2025-06-1120,929245,497
Scott LishRSU2025-06-1121,751255,139
Patrick MilesRSU2025-01-29389,1954,693,692
Craig HunsakerRSU2025-06-1121,751255,139
Patrick MilesRSU2025-06-1116,475193,252
Craig HunsakerRSU2025-01-29195,1262,353,220
Scott LishPSU2025-01-29173,417346,8342,091,409
David SponselPSU2025-01-29114,322228,6441,378,723
J. Todd KoningPSU2025-01-29114,322228,6441,378,723
Scott LishRSU2025-01-29193,3172,331,403
Patrick MilesPSU2025-01-29340,955681,9104,111,917
David SponselRSU2025-01-29135,4281,633,262
Craig HunsakerPSU2025-01-29173,417346,8342,091,409
David SponselRSU2025-06-113,86645,348
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
J. Todd Koning$1,860,572$1,378,723$042.6%
Scott Lish2,586,5422,091,409044.7%
Patrick Miles4,886,9444,111,917045.7%
Craig Hunsaker2,608,3592,091,409044.5%
David Sponsel1,678,6101,378,723045.1%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Patrick MilesPSU340,955$7,173,693
Craig HunsakerRSU30,475641,194
David SponselRSU20,007420,947
Craig HunsakerPSU61,5661,295,349
Patrick MilesPSU103,3912,175,347
Patrick MilesRSU68,2381,435,728
David SponselPSU89,0601,873,819
Craig HunsakerPSU46,175971,522
J. Todd KoningPSU43,204909,012
Craig HunsakerRSU27,460577,758
J. Todd KoningRSU21,385449,940
Scott LishRSU173,4173,648,694
Scott LishRSU16,527347,728
Patrick MilesPSU207,7554,371,163
Patrick MilesPSU137,8542,900,448
Craig HunsakerPSU104,6222,201,257
Patrick MilesRSU54,5291,147,290
David SponselPSU40,418850,395
Scott LishPSU33,388702,484
David SponselPSU30,314637,807
Craig HunsakerRSU173,4173,648,694
Scott LishPSU25,041526,863
Scott LishPSU173,4173,648,694
J. Todd KoningPSU32,403681,759
David SponselRSU23,375491,810
Craig HunsakerPSU173,4173,648,694
Patrick MilesRSU340,9557,173,693
J. Todd KoningRSU114,3222,405,335
J. Todd KoningPSU114,3222,405,335
David SponselRSU114,3222,405,335
David SponselPSU114,3222,405,335
J. Todd KoningPSU80,6351,696,553
Scott LishPSU80,6351,696,553
J. Todd KoningRSU21,164445,291
Scott LishRSU21,164445,291
05

Incentive-plan design — the Compensation Discussion & Analysis

The Compensation Committee has embraced a philosophy of "pay-for-performance," whereby an individual's experience, potential, and contribution to our business determines a substantial portion of his or her actual compensation. The Compensation Committee seeks to: (i) provide meaningful incentives for the attainment of specific financial or operational objectives; (ii) reward those executive officers who make substantial contributions to the attainment of those objectives; and (iii) link executive officer compensation with Company and individual performance.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)
Independent consultantCompensia, Inc.
Clawback policytrue
Anti-hedging
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-1081,927,39512,420,476293,21986.84%Passed
20252025-06-1182,619,8036,064,61265,96993.16%Passed
20242024-06-1269,776,29112,628,16449,82584.68%Passed
20232023-06-1456,507,999728,68530,49398.73%Passed
20222022-06-1537,605,39318,739,526356,64366.74%Passed
20212021-06-1655,107,4273,693,015591,63493.72%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-1086.84%a
20252025-06-1193.16%b
20242024-06-1284.68%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)77.8 : 1
CEO total compensation$10,260,507
Median employee compensation$131,967
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Karen McGinnisIndependent$72,500$177,487$249,987
Mortimer BerkowitzIndependent65,000177,487242,487
Quentin BlackfordIndependent62,500177,487239,987
Ward WoodsIndependent60,000177,487237,487
Keith ValentineIndependent50,000177,487227,487
David DemskiIndependent45,000177,487222,487
David PelizzonIndependent45,000177,487222,487
09

Board fee structure and ownership guideline

Annual cash retainer$45,000
Annual equity retainer$177,487
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)20,000 / 15,000 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$400,000
Equity awards (grant-date value)$1,242,409
All other compensation$0
Total cost of the board$1,642,409

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Alphatec Holdings names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Alphatec Holdings.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1TransMedics Group2025Waleed Hassanein$776,923$4,364,013$4,360,147$1,400,000$10,915,533
2Alphatec Holdings2025Patrick Miles762,0008,859,6500600,00010,260,507
3Maravai Life Sciences Holdings2025Bernd Brust388,8637,660,0001,460,000425,34310,129,708
4Inspire Medical Systems2025Timothy Herbert750,5725,999,6550961,5577,711,784
5STAAR Surgical2025Stephen Farrell580,0006,836,000007,522,385
6Tandem Diabetes Care2025John Sheridan790,5835,367,7960674,0906,858,503
7Treace Medical Concepts2025John Treace755,3534,635,000005,405,190
8OraSure Technologies2025Carrie Eglinton Manner721,0003,394,1880173,0404,292,228
9LeMaitre Vascular2025George LeMaitre806,3471,050,0001,050,000680,0153,780,990
10Tactile Systems Technology2025Sheri Dodd675,0002,019,9780737,4383,466,916

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Alphatec Holdings157%PSU 50 · RSU 50NoCompensia, Inc.
Inspire Medical Systems111.4%PSU 50 · RSU 50NoAon
LeMaitre Vascular144%Options 50 · RSU 25 · PSU 25Nonot disclosed
Maravai Life Sciences Holdingsnot disclosednot disclosedNoMeridian Compensation Partners, LLC
OraSure Technologies24.0%RSU 50 · PSU 50Yes — Relative TSR performance vs peer groupPay Governance LLC
STAAR Surgical135%RSU 50 · PSU 50NoSemler Brossy
Tactile Systems Technology115%PSU 50 · RSU 50NoAon Consulting, Inc.
Tandem Diabetes Care87%PSU 50 · RSU 50Yes — TSR performance compared to the Russell 3000 index in the three-year period between 2025 and 2027WTW
TransMedics Group175%Options 50 · RSU 50not disclosedPearl Meyer
Treace Medical Conceptsnot disclosedRSU 50 · PSU 50NoCompensia, Inc.

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Patrick MilesDEF 14A2026-04-290001193125-26-191867Section “2025 Summary Compensation Table”. As printed: 10,260,507. Filing ↗machine: t26 · r2 · c25 · span 858148–858158
2Section 01, Craig HunsakerDEF 14A2026-04-290001193125-26-191867Section “2025 Summary Compensation Table”. As printed: 6,319,872. Filing ↗machine: t26 · r8 · c25 · span 920209–920218
3Section 01, Scott LishDEF 14A2026-04-290001193125-26-191867Section “2025 Summary Compensation Table”. As printed: 5,271,245. Filing ↗machine: t26 · r14 · c25 · span 982119–982128
4Section 01, David SponselDEF 14A2026-04-290001193125-26-191867Section “2025 Summary Compensation Table”. As printed: 3,954,407. Filing ↗machine: t26 · r11 · c25 · span 951186–951195
5Section 01, J. Todd KoningDEF 14A2026-04-290001193125-26-191867Section “2025 Summary Compensation Table”. As printed: 3,829,875. Filing ↗machine: t26 · r5 · c25 · span 889176–889185
6Section 03, J. Todd Koning RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r12 · c9 · span 1099454–1099463
7Section 03, J. Todd Koning RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r13 · c9 · span 1103362–1103369
8Section 03, Scott Lish RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r31 · c9 · span 1172728–1172735
9Section 03, Patrick Miles RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r6 · c9 · span 1076328–1076337
10Section 03, Craig Hunsaker RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r19 · c9 · span 1126486–1126493
11Section 03, Patrick Miles RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r7 · c9 · span 1080236–1080243
12Section 03, Craig Hunsaker RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r18 · c9 · span 1122578–1122587
13Section 03, Scott Lish PSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r29 · c9 · span 1164911–1164920
14Section 03, David Sponsel PSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r23 · c9 · span 1141795–1141804
15Section 03, J. Todd Koning PSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r11 · c9 · span 1095545–1095554
16Section 03, Scott Lish RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r30 · c9 · span 1168820–1168829
17Section 03, Patrick Miles PSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r5 · c9 · span 1072419–1072428
18Section 03, David Sponsel RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r24 · c9 · span 1145704–1145713
19Section 03, Craig Hunsaker PSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r17 · c9 · span 1118669–1118678
20Section 03, David Sponsel RSUDEF 14A2026-04-290001193125-26-191867Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r25 · c9 · span 1149611–1149617
21Section 07, pay ratioDEF 14A2026-04-290001193125-26-191867Section “CEO Pay Ratio”. As printed: 77.8 : 1. Filing ↗machine: span 833563–833570
22Section 08, Karen McGinnisDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 249,987. Filing ↗machine: t34 · r5 · c11 · span 1747997–1748004
23Section 08, Mortimer BerkowitzDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 242,487. Filing ↗machine: t34 · r2 · c11 · span 1732999–1733006
24Section 08, Quentin BlackfordDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 239,987. Filing ↗machine: t34 · r3 · c11 · span 1738001–1738008
25Section 08, Ward WoodsDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 237,487. Filing ↗machine: t34 · r8 · c11 · span 1763267–1763274
26Section 08, Keith ValentineDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 227,487. Filing ↗machine: t34 · r7 · c11 · span 1757996–1758003
27Section 08, David DemskiDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 222,487. Filing ↗machine: t34 · r4 · c11 · span 1742998–1743005
28Section 08, David PelizzonDEF 14A2026-04-290001193125-26-191867Section “Director Compensation”. As printed: 222,487. Filing ↗machine: t34 · r6 · c11 · span 1752996–1753003
29Section 02, Keith Valentine 2026-05-07Form 42026-05-110001289408-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Keith Valentine 2026-05-07Form 42026-05-110001289408-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Keith Valentine 2026-05-07Form 42026-05-110001289408-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Keith Valentine 2026-06-10Form 42026-06-120001289408-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, David Pelizzon 2026-06-10Form 42026-06-120001719217-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, David Demski 2026-06-10Form 42026-06-120001555392-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Quentin Blackford 2026-06-10Form 42026-06-120001612451-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Karen McGinnis 2026-06-10Form 42026-06-120001188264-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Karen McGinnis 2026-06-10Form 42026-06-120001188264-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
38Section 06, 2026 voteForm 8-K2026-06-110001193125-26-267552Item 5.07 · say-on-pay result. As reported: 86.84% (votes for as printed: 81,927,395). Filing ↗
39Section 06, 2025 voteForm 8-K2025-06-130000950170-25-086130Item 5.07 · say-on-pay result. As reported: 93.16% (votes for as printed: 82,619,803). Filing ↗
40Section 06, 2024 voteForm 8-K2024-06-170000950170-24-073859Item 5.07 · say-on-pay result. As reported: 84.68% (votes for as printed: 69,776,291). Filing ↗
41Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
42Section 09b board cost (computed)ComputedcomputedCash 400,000 + equity 1,242,409 + all other 0 = 1,642,409, summed across the director compensation table rows.machine: formula: Σ = 1,642,409
43TransMedics Group, Section 10b CEO totalDEF 14A2026-04-100001193125-26-150357CEO total compensation as printed in TransMedics Group's own proxy. As printed: 10,915,533. Filing ↗machine: r3 · c39 · span 572169–572179
44Alphatec Holdings (subject), Section 10b CEO totalDEF 14A2026-04-290001193125-26-191867CEO total compensation as printed in Alphatec Holdings's own proxy. As printed: 10,260,507. Filing ↗machine: t26 · r2 · c25 · span 858148–858158
45Maravai Life Sciences Holdings, Section 10b CEO totalDEF 14A2026-04-240001823239-26-000014CEO total compensation as printed in Maravai Life Sciences Holdings's own proxy. As printed: 10,129,708. Filing ↗machine: t21 · r3 · c20 · span 502645–502655
46Inspire Medical Systems, Section 10b CEO totalDEF 14A2026-03-200001140361-26-010490CEO total compensation as printed in Inspire Medical Systems's own proxy. As printed: 7,711,784. Filing ↗machine: r2 · c25 · span 1164868–1164877
47STAAR Surgical, Section 10b CEO totalDEF 14A2026-05-040000718937-26-000015CEO total compensation as printed in STAAR Surgical's own proxy. As printed: 7,522,385. Filing ↗machine: r3 · c16 · span 1045477–1045486
48Tandem Diabetes Care, Section 10b CEO totalDEF 14A2026-04-070001438133-26-000034CEO total compensation as printed in Tandem Diabetes Care's own proxy. As printed: 6,858,503. Filing ↗machine: r3 · c27 · span 866963–866972
49Treace Medical Concepts, Section 10b CEO totalDEF 14A2026-04-060001630627-26-000005CEO total compensation as printed in Treace Medical Concepts's own proxy. As printed: 5,405,190. Filing ↗machine: t81 · r4 · c16 · span 1034150–1034159
50OraSure Technologies, Section 10b CEO totalDEF 14A2026-04-300001116463-26-000032CEO total compensation as printed in OraSure Technologies's own proxy. As printed: 4,292,228. Filing ↗machine: t152 · r2 · c21 · span 850376–850385
51LeMaitre Vascular, Section 10b CEO totalDEF 14A2026-04-140001193125-26-153877CEO total compensation as printed in LeMaitre Vascular's own proxy. As printed: 3,780,990. Filing ↗machine: span 564038–564047
52Tactile Systems Technology, Section 10b CEO totalDEF 14A2026-03-250001104659-26-034206CEO total compensation as printed in Tactile Systems Technology's own proxy. As printed: 3,466,916. Filing ↗machine: r3 · c12 · span 865797–865806
53Section 10a, Tactile Systems Technology reciprocityDEF 14A0001104659-26-034206Tactile Systems Technology's most recent proxy was read; its disclosed peer group does not include Alphatec Holdings. Filing ↗
54Section 10a, TransMedics Group reciprocityDEF 14A0001193125-26-150357TransMedics Group's most recent proxy was read; its disclosed peer group does not include Alphatec Holdings. Filing ↗
55Section 10a, Treace Medical Concepts reciprocityDEF 14A0001630627-26-000005Treace Medical Concepts names Alphatec Holdings in its own disclosed peer group (read from its most recent proxy). Filing ↗
56Section 10a, Tandem Diabetes Care reciprocityDEF 14A0001438133-26-000034Tandem Diabetes Care's most recent proxy was read; its disclosed peer group does not include Alphatec Holdings. Filing ↗
57Section 10a, Inspire Medical Systems reciprocityDEF 14A0001140361-26-010490Inspire Medical Systems's most recent proxy was read; its disclosed peer group does not include Alphatec Holdings. Filing ↗
58Section 10a, STAAR Surgical reciprocityDEF 14A0000718937-26-000015STAAR Surgical names Alphatec Holdings in its own disclosed peer group (read from its most recent proxy). Filing ↗
59Section 10a, Maravai Life Sciences Holdings reciprocityDEF 14A0001823239-26-000014Maravai Life Sciences Holdings's most recent proxy was read; its disclosed peer group does not include Alphatec Holdings. Filing ↗
60Section 10a, OraSure Technologies reciprocityDEF 14A0001116463-26-000032OraSure Technologies's most recent proxy was read; its disclosed peer group does not include Alphatec Holdings. Filing ↗